Phase 1 combination study of eribulin mesylate with trastuzumab for advanced or recurrent human epidermal growth factor receptor 2 positive breast cancer.
about
Eribulin in the Management of Advanced Breast Cancer: Implications of Current Research FindingsEribulin in Cancer TreatmentEribulin for the treatment of metastatic breast cancer: an update on its safety and efficacyPertuzumab for the treatment of patients with human epidermal growth factor receptor 2-positive breast cancer in Japan.Review on the clinical use of eribulin mesylate for the treatment of breast cancer.Eribulin in non-small cell lung cancer: challenges and potential strategies.Eribulin in advanced breast cancer: safety, efficacy and new perspectives.Pertuzumab, trastuzumab and eribulin mesylate therapy for previously treated advanced HER2-positive breast cancer: a feasibility study with analysis of biomarkers.
P2860
Q26774097-FBC1677C-F75B-4F65-BC88-A7D6990217C0Q26799328-967BAD7F-82E6-41BF-ABEC-8A8B5F1BFA42Q28088354-9291D3B6-59B8-47AD-8F54-A2DD133036F8Q36336483-7E470A90-5AE1-43C4-822A-C8C6DB35B215Q38711371-099A11E5-BF4B-487C-9DB4-722F1716F4ADQ39120142-08FC1B8C-8C10-45C6-86D8-E9284AF7D6DDQ47794057-72C0B5EE-6A5E-489F-8AA0-562D0B57E30BQ55078620-25F6EE27-FE92-4955-96B9-E667DBB6B243
P2860
Phase 1 combination study of eribulin mesylate with trastuzumab for advanced or recurrent human epidermal growth factor receptor 2 positive breast cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Phase 1 combination study of e ...... ptor 2 positive breast cancer.
@ast
Phase 1 combination study of e ...... ptor 2 positive breast cancer.
@en
Phase 1 combination study of e ...... ptor 2 positive breast cancer.
@nl
type
label
Phase 1 combination study of e ...... ptor 2 positive breast cancer.
@ast
Phase 1 combination study of e ...... ptor 2 positive breast cancer.
@en
Phase 1 combination study of e ...... ptor 2 positive breast cancer.
@nl
prefLabel
Phase 1 combination study of e ...... ptor 2 positive breast cancer.
@ast
Phase 1 combination study of e ...... ptor 2 positive breast cancer.
@en
Phase 1 combination study of e ...... ptor 2 positive breast cancer.
@nl
P2093
P2860
P1476
Phase 1 combination study of e ...... ptor 2 positive breast cancer.
@en
P2093
Hirofumi Mukai
Hiroshi Obaishi
Ken Shimada
Masayuki Namiki
Nobuaki Matsubara
Tadashi Nakanishi
Toshiaki Saeki
Yasutsuna Sasaki
Yoichi Naito
P2860
P2888
P304
P356
10.1007/S10637-014-0161-Y
P577
2014-09-23T00:00:00Z
P5875
P6179
1019149483